Insiders Invitae Corporation

Equities

NVTA.Q

US46185L1035

End-of-day quote OTC Markets Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
0.0006 ^USD	-88.00%		-82.86%	-99.90%

04-25	Labcorp beats quarterly estimates on strong testing demand	RE
04-25	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	RE

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Invitae Corporation Announces Board Changes	12-11	CI
Invitae Corporation Announces the Retirement of Robert L. Nussbaum as Chief Medical Officer, Effective December 29, 2023	11-17	CI
Invitae Corporation Appoints Ana J. Schrank as Chief Accounting Officer	11-15	CI
Invitae Names David Sholehvar Chief Operating Officer	19/10/23	MT
Invitae Corporation Appoints David Sholehvar as Chief Operating Officer, Effective November 13, 2023	19/10/23	CI
Invitae Names Ana Schrank as CFO	25/09/23	MT
Invitae Appoints Robert Guigley as Chief Commercial Officer	28/08/23	MT
Invitae Appoints Robert Dickey as Interim CFO	14/08/23	MT
Invitae Corporation Announces Board Changes	14/08/23	CI
Invitae Corporation Announces Executive Changes	05/07/23	CI
Invitae Corporation Appoints Christine M. Gorjanc as Interim Chief Financial Officer	05/07/23	CI
Invitae's Finance Chief Yafei Wen Resigns; Interim CFO Named	26/05/23	MT
Invitae Corporation Announces Resignation of Robert F. Werner as Chief Accounting Officer and Principal Accounting Officer	28/04/23	CI
Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology	16/03/23	CI
Invitae Corporation Appoints William H. Osborne to its Board of Directors	30/01/23	CI
Invitae Executive Appointed to National Health Information Technology Advisory Committee	19/12/22	PR
Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthcare	27/09/22	PR
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	25/08/22	MT
Insider Sell: Invitae	18/08/22	MT
Invitae Posts Q2 Preliminary Revenue, Announces Strategic Realignment; Names Kenneth Knight as CEO, Randy Scott as Chairman	18/07/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Invitae Corporation

Equities

NVTA.Q

US46185L1035

Insiders

Filters